|
Sign In to gain access to subscriptions and/or personal tools.
|
Dantrolene Counteracts the Masseter Muscle Damage Induced by Artificial Occlusal Wear: Studies in a Rat Model
D. Bani
'Department of Anatomy, Histology and Forensic Medicine, Section of Histology, University of Florence, V. le G. Pieraccini, 6, 1-50139 Florence, Italy, bani{at}unifi.it
M. Bergamini
Department of Odontostomatology, University of Florence, V. le G. Pieraccini, 6, 1-50139 Florence, Italy
In previous studies, we showed that the introduction of occlusal alterations to rats results in masseter muscle abnormalities. Here, we investigate whether administration of the muscle relaxant dantrolene to rats with occlusal alteration could counteract the occurrence of such abnormalities. Rats underwent unilateral amputation of molar cusps to cause malocclusion. Some rats received dantrolene (10 mg/kg/day subcutaneously). The masseter muscles ipsilateral to the amputated molars were excised 26 days later. Sham-operated rats were used as controls. The tissue samples were studied by light and electron microscopy and morphometry. Moreover, tissue Ca2+ content, an index of muscle injury, was determined. In the absence of dantrolene, occlusal alteration leads to microvessel constriction, morphologic damage of masseter muscle fibers and blood capillaries, and elevation of tissue Ca2+ content. These changes were nearly abrogated by dantrolene, thus supporting it as a possible new therapeutic tool for the treatment of malocclusion-induced muscle diseases.
Key Words: Dantrolene masseter muscle occlusal wear temporomandibular disorders.
REFERENCES
- Bani D., Bani T., Bergamini M. (1999). Morphologic and biochemical changes of the masseter muscles induced by occlusal wear. Studies in a rat model. J Dent Res 78:1735-1744.
- Bennett RM (1990). Myofascial pain syndromes and fibromyalgia syndrome: a comparative analysis. Adv Pain Res Ther 17:43-65.
- Bergamini M., Prayer-Galletti S. (1992). Systematic manifestations of musculoskeletal disorders related to masticatory dysfunctions. In: Anthology of craniomandibular orthopedics. Coy RE, editor. Vol. 2. Collingsville, IL: Buchanan, pp. 89-102.
- Dawson P. (1974). Evaluation, diagnosis and treatment of occlusal problems. St. Louis, MO: C.V. Mosby.
- Fruen BR, Mickelson JR, Louis CF (1997). Dantrolene inhibition of sarcoplasmic reticulum Ca2+ release by direct and specific action at the skeletal muscle ryanodine receptors. J Biol Chem 272:26965-26971.[Abstract/Free Full Text]
- Giulumian AD, Meszaros LG, Fuchs LC (2000). Endothelin-1-induced contraction of mesenteric small arteries is mediated by ryanodine receptor Ca2+ channels and cyclic ADP-ribose. J Cardiovasc Pharmacol 36:758-763.[Medline]
[Order article via Infotrieve]
- Kirveskari P. (1978). Credibility of morphologic and psychologic theories of TMJ pain-dysfunction aetiology. J Oral Rehabil 5:201-205.[Medline]
[Order article via Infotrieve]
- Mense S. (1994). Referral of muscle pain: new aspects. Am Pain Soc J 3:1-9.
- Mickelson JR, Louis CF (1996). Malignant hyperthermia: excitation-contraction coupling, Ca2+ release channel, and cell Ca2+ regulation defects. Physiol Rev 76:537-592.[Abstract/Free Full Text]
- Niebauer M., Gruenthal M. (1999). Neuroprotective effects of early vs. late administration of dantrolene in experimental status epilepticus. Neuropharmacology 38:1343-1348.[CrossRef][Medline]
[Order article via Infotrieve]
- Paul-Pletzer K., Palnitkar SS, Jimenez LS, Morimoto H., Parness J. (2001). The skeletal muscle ryanodine receptor identified as a molecular target of [3H]azidodantrolene by photoaffinity labeling. Biochemistry 40:531-542.[CrossRef][Medline]
[Order article via Infotrieve]
- Simons DG (1987). Myofascial pain syndrome due to trigger points. Monograph series. No. 1. Rademaker, OH, USA: International Rehabilitation Medicine Association.
- Simons DG, Travell JG (1981). Myofascial trigger points, a possible explanation. Pain 10:106-109.[CrossRef][Medline]
[Order article via Infotrieve]
- Simons DG, Travell JG, Simons LS (1999). Travell & Simons' myofascial pain and dysfunction: the trigger point manual. 2nd ed. Vol. 1, Chapter 2. Baltimore: Williams & Wilkins, pp. 11-93.
- Travell JG (1976). Myofascial trigger points: clinical view. In: Advances in pain research and therapy. Bonica JJ, Albe-Fessard D, editors. Vol. 1. New York: Raven Press, pp. 919-926.
- Trudeau DL, Freier EF (1967). Determination of calcium in urine and serum by atomic absorption spectrophotometry (AAS). Clin Chem 13:101-114.[Abstract]
Journal of Dental Research, Vol. 80, No. 11,
1990-1994 (2001)
DOI: 10.1177/00220345010800110801

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|